news
A new blood-brain barrier-crossing platform enables the delivery of therapeutic…
27 November 2024 | By Drug Target Review
A new blood-brain barrier-crossing platform enables the delivery of therapeutic molecules to the brain, offering potential treatments for ALS and Alzheimer’s disease.